|
Exposure
|
Model
|
Model I
|
Model II
|
|---|
|
NLR group
|
OR (95%CI) P
|
OR (95%CI) P
|
OR (95%CI) P
|
|
ContinuousNLR
|
1.46 (1.19,1.78) 0.000**
|
1.46 (1.18,1.81) 0.000**
|
1.37 (1.06,1.78) 0.018*
|
|
0.46–1.49
|
1
|
1
|
1
|
|
1.50-1.95
|
1.89 (1.12,3.17) 0.016*
|
2.11 (1.19,3.73) 0.011*
|
1.23 (0.62, 2.44) 0.556
|
|
1.95–2.54
|
2.25 (1.33,3.79) 0.002**
|
2.51 (1.42,4.46) 0.002**
|
1.77 (0.88, 3.55) 0.110
|
|
2.54–11.05
|
3.44 (2.01,5.89) 0.000**
|
3.61 (1.99,6.55) 0.000**
|
2.80 (1.32, 5.95) 0.007**
|
|
P for trend
|
0.000**
|
0.000**
|
0.004**
|
- Model: crude model; Model I: adjusting for age, gender, diabetes duration; Model II: adjusting for age, gender, diabetes duration, hypertension, BMI, Scr, WBC, Hb, BUN, TG, FPG and HbA1c
- NLR neutrophil-to-lymphocyte ratio,OR odds ratios, CI confidence intervals, BMI body mass index, Scr serum creatinine, WBC white blood cell, Hb hemoglobin, BUN blood urea nitrogen, TG triglycerides, FPG fasting plasma glucose, HbA1c glycated hemoglobin A1c
- *P < 0.05, **P < 0.01
